Now showing items 1-1 of 1

    • Country-based report: The safety of omalizumab treatment in pregnant patients with asthma 

      Gemicioğlu B,Yalçin AD,Havlucu Y,Karakaya G,Özdemir L,Keren M,Bavbek S,Ediger D,Oğuzülgen İK,Özşeker ZF,Yorgancioğlu A (2021)
      Background/aim: We aimed to report outcomes of pregnant patients with asthma under omalizumab treatment and their infants in our country. Materials and methods: Patients with asthma who received omalizumab for at least 6 ...